Friday December 15th 2017

Serum Lipid and Antiphospholipid Antibodies Profiles in Different Phases of Multiple Sclerosis (P6.142)

CONCLUSIONS:Based on our findingswe hypothesize that the pro-inflammatory and thrombogenic processes associated with dyslipidemia could contribute to disease progression in MS via diverse mechanisms at vascular endothelium of blood brain barrier. However, further studies with larger populations are needed to confirm our preliminary data.Study Supported by:Disclosure: Dr. Koudriavtseva has received personal compensation for activities with Bayer Schering as a speaker. Dr. Mandoj has nothing to disclose. Dr. Cigliana has nothing to disclose. Dr. D’Agosto has nothing to disclose. Dr. Cordiali-Fei has nothing to disclose. Dr. Conti has nothing to disclose. (Source: Neurology)

MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.

Jump to original:

Serum Lipid and Antiphospholipid Antibodies Profiles in Different Phases of Multiple Sclerosis (P6.142)

Leave a Comment

More from category

Germany’s Merck to make new bid to enter U.S. MS pill market
Germany’s Merck to make new bid to enter U.S. MS pill market

FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the [Read More]

Researchers develop new method for quickly detecting signs of multiple sclerosis
Researchers develop new method for quickly detecting signs of multiple sclerosis

A METHOD for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research [Read More]

Terror survivors have increased risk of frequent migraine, tension headaches
Terror survivors have increased risk of frequent migraine, tension headaches

Survivors of a terror attack have an increased risk of frequent migraine and tension headaches after the attack, [Read More]

Scientists discover blood sample detection method for multiple sclerosis
Scientists discover blood sample detection method for multiple sclerosis

(University of Huddersfield) Researchers identified two natural biomarker compounds present in the blood. (Source: [Read More]

Study: The medical community isn’t prepared for the looming pandemic of neurodegenerative diseases like Parkinson’s
Study: The medical community isn’t prepared for the looming pandemic of neurodegenerative diseases like Parkinson’s

(Natural News) Parkinson’s disease is the second most common neurodegenerative disease plaguing people today, with an [Read More]